CLLS
Cellectis (CLLS)
$69
About Cellectis (CLLS)
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Details
Daily high
$2.80
Daily low
$2.35
Price at open
$2.80
52 Week High
$5.48
52 Week Low
$2.35
Market cap
201.8M
Dividend yield
0.00%
Volume
69,080
Avg. volume
13,033
P/E ratio
-4.14
Cellectis News
Details
Daily high
$2.80
Daily low
$2.35
Price at open
$2.80
52 Week High
$5.48
52 Week Low
$2.35
Market cap
201.8M
Dividend yield
0.00%
Volume
69,080
Avg. volume
13,033
P/E ratio
-4.14